Previous Close | 3.1000 |
Open | N/A |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 400.00 |
Expire Date | 2025-06-20 |
Day's Range | 3.1000 - 3.1000 |
Contract Range | N/A |
Volume | |
Open Interest | 3 |
Novo Nordisk CEO Lars Jørgensen tells Yahoo Finance the company is confident about a robust GLP-1 sales year despite missing Wall Street estimates.
Futures tied to Wall Street's main indexes gained on Friday, lifted by upbeat corporate updates from Apple and Amgen, while traders braced for a key jobs report for a clearer outlook on the labor market and the interest rate path. Apple jumped 6.1%, outpacing other megacap stocks in premarket trading after the iPhone maker unveiled a record $110 billion share buyback program and beat modest expectations for quarterly results and forecast.
(Bloomberg) -- Amgen Inc.’s shares soared after its chief executive officer said he was “very encouraged” by early results from a study of the company’s experimental obesity drug, MariTide. Most Read from BloombergSaudi Arabia Steps Up Arrests Of Those Attacking Israel OnlineApple Rallies on Upbeat Forecast, Record-Setting BuybackTurkey Confirms All Trade Halt With Israel Over War in GazaHuawei Secretly Backs US Research, Awarding Millions in PrizesIn Jamie Dimon's America, the Stock Market Has